# Commission Decision of 8 May 2001 relating to a proceeding pursuant to Article 81 of the EC Treaty Cases: IV/36.957/F3 Glaxo Wellcome (notification), IV/36.997/F3 Aseprofar and Fedifar (complaint), IV/37.121/F3 Spain Pharma (complaint), IV/37.138/F3 BAI (complaint), IV/37.380/F3 EAEPC (complaint) (notified under document number C (2001) 1202) (Text with EEA relevance.) (revoked)

EU Decision 2001/791 · adopted 8 May 2001

## Introductory text

Commission Decision of 8 May 2001 relating to a proceeding pursuant to Article 81 of the EC Treaty Cases: IV/36.957/F3 Glaxo Wellcome (notification), IV/36.997/F3 Aseprofar and Fedifar (complaint), IV/37.121/F3 Spain Pharma (complaint), IV/37.138/F3 BAI (complaint), IV/37.380/F3 EAEPC (complaint) (notified under document number C (2001) 1202) (Text with EEA relevance.) (revoked)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Articles 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/eudn/2001/791 (the official version)
Page: https://openlegislation.uk/eu-decision-2001-791
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.